Christina Treppendahl
Nurse Practitioner · Ridgeland, MSNPI 1922273499
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $98,067 of the $124,571 with a category attached, or 78.7%. 12 manufacturers reported payments, led by Upsher-smith Laboratories LLC at 32.1% of the total. Reporting peaked in 2021 at $74,220 and has fallen 92.3% since, to $5,720 in 2023. Among nurse practitioner clinicians in MS with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 275 payments — averaging $452.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Upsher-smith Laboratories LLC$40K
- Lilly USA, LLC$23K
- Amgen$17K
- AbbVie$16K
- Biohaven Pharmaceuticals, Inc.$12K
- Teva Pharmaceuticals USA, Inc.$9K
- plus $8K from 6 others
Across 210 payments — averaging $2609.59 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AbbVie$230K
- Teva Pharmaceuticals USA, Inc.$216K
- H. Lundbeck A S$68K
- Novartis$21K
- Supernus Pharmaceuticals, Inc.$13K
What the payments were for
- Consulting fees$9,7908%
- Speaking & faculty fees$98,06779%
- Grants$440%
- Travel & lodging$11,7569%
- Food & beverage$4,8734%
- Education$420%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Upsher-smith Laboratories LLC | 56 | $39,937 |
| Lilly USA, LLC | 36 | $23,357 |
| Amgen | 43 | $16,965 |
| AbbVie(2 entities) | 63 | $16,456 |
| Biohaven Pharmaceuticals, Inc. | 32 | $11,732 |
| Teva Pharmaceuticals USA, Inc. | 12 | $8,527 |
| Lundbeck LLC | 10 | $4,689 |
| Biohaven Pharmaceutical Holding Company Ltd. | 4 | $2,552 |
| Novartis | 15 | $214 |
| Impel Pharmaceuticals Inc. | 1 | $84 |
| Supernus Pharmaceuticals, Inc. | 2 | $38 |
| Novo Nordisk | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TOSYMRA$37,804
- EMGALITY$20,750
- AIMOVIG$16,440
- UBRELVY$15,323
- NURTEC ODT$13,754
- ZEMBRACE SYMTOUCH$10,589
- REYVOW$9,375
- AJOVY$8,458
- VYEPTI$4,500
- BOTOX$249
How this compares
$124,571 in reported general payments places this provider in the 95th percentile of 1,090 nurse practitioner providers in Mississippi.
Other nurse practitioner in Ridgeland
- Gagandeep BalRidgeland$13K
- Kenneth KaiserRidgeland$11K
- Jo Anna WarrenJackson$73K
- Marisa StringerBiloxi$68K
- Sara KlausFlowood$48K
- Micaela PerkinsOxford$32K
- Michelle TharpJackson$28K
- Kaylon LewisHattiesburg$25K
- Jennifer HollyJackson$16K
- Mariah CoxGulfport$14K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.